HMG CoA reductase inhibitors for treatment of hyperlipidemia.
Where this comes from
- Record sourced from PubMed, PMID 8503348.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
Lowering serum cholesterol levels in patients with hyperlipidemia has been shown to decrease deaths due to coronary heart disease. While diet is the mainstay of treatment for hyperlipidemia, drug therapy is necessary to achieve treatment goals in certain patients. The HMG CoA reductase inhibitors are the most effective cholesterol-lowering agents currently available. These agents are well tolerated and have few serious side effects. Their major disadvantage is their high cost.